Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-07 9:14 pm Purchase | 2026-03-31 | 13D | ONKURE THERAPEUTICS, INC. CLAS OKUR | AI Biotechnology LLC | 9,091,532 19.990% | 9,091,532![]() (New Position) | Filing History |
| 2026-04-07 7:21 pm Purchase | 2026-03-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | StepStone Group LP | 2,660,612 6.600% | 2,660,612![]() (New Position) | Filing History |
| 2026-04-07 4:30 pm Purchase | 2026-03-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Trails Edge Capital Partners, LP | 2,409,638 6.000% | 2,409,638![]() (New Position) | Filing History |
| 2026-04-07 4:13 pm Purchase | 2026-03-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | RA Capital Management, L.P. | 4,038,715 9.900% | 4,038,715![]() (New Position) | Filing History |
| 2026-04-01 11:17 am Purchase | 2026-03-27 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | ACORN BIOVENTURES, L.P. | 3,924,037 9.500% | 1,084,363![]() (+38.19%) | Filing History |
| 2026-02-17 8:15 pm Purchase | 2025-12-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | ADAR1 Capital Management, LLC | 1,014,158 7.900% | 1,014,158![]() (New Position) | Filing History |
| 2026-02-17 4:53 pm Sale | 2025-12-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Citadel Advisors LLC | 223,125 1.700% | -1,048,246![]() (-82.45%) | Filing History |
| 2026-02-17 4:10 pm Sale | 2025-12-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Highbridge Capital Management, LLC | 542,361 4.200% | -121,246![]() (-18.27%) | Filing History |
| 2026-01-30 2:21 pm Sale | 2025-12-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | The Vanguard Group | 626,593 4.870% | -80,140![]() (-11.34%) | Filing History |
| 2025-11-28 08:15 am Purchase | 2025-11-24 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Prosight Management, LP | 745,649 5.800% | 745,649![]() (New Position) | Filing History |
| 2025-08-14 5:28 pm Sale | 2025-06-30 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Samsara BioCapital, L.P. | 0 0.000% | -824,155![]() (Position Closed) | Filing History |
| 2025-08-14 5:20 pm Sale | 2025-06-30 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Perceptive Advisors LLC | 0 0.000% | -1,004,439![]() (Position Closed) | Filing History |
| 2025-08-14 4:09 pm Purchase | 2025-06-30 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Highbridge Capital Management, LLC | 663,607 5.200% | 263,864![]() (+66.01%) | Filing History |
| 2025-08-14 4:05 pm Purchase | 2025-06-30 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | CANTOR FITZGERALD & CO. | 669,539 5.200% | 669,539![]() (New Position) | Filing History |
| 2025-05-30 3:57 pm Unchanged | 2025-05-15 | 13D | ONKURE THERAPEUTICS, INC. CLAS OKUR | ACORN BIOVENTURES, L.P. | 2,839,674 22.100% | 0 (Unchanged) | Filing History |
| 2025-05-29 4:33 pm Purchase | 2025-05-15 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Shay Capital LLC | 810,214 6.300% | 810,214![]() (New Position) | Filing History |
| 2025-05-22 4:49 pm Purchase | 2025-05-15 | 13D | ONKURE THERAPEUTICS, INC. CLAS OKUR | ACORN BIOVENTURES, L.P. | 2,839,674 22.100% | 1,400,000![]() (+97.24%) | Filing History |
| 2025-05-19 3:02 pm Sale | 2025-05-15 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Cormorant Asset Management, LP | 0 0.000% | -1,837,739![]() (Position Closed) | Filing History |
| 2025-02-14 08:48 am Sale | 2024-12-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Deep Track Capital, LP | 523,989 4.140% | -136,147![]() (-20.62%) | Filing History |
| 2025-02-07 4:15 pm Sale | 2024-12-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Highbridge Capital Management, LLC | 399,743 3.200% | -2,662,947![]() (-86.95%) | Filing History |

